atazanavir sulfate has been researched along with telaprevir in 5 studies
| Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (telaprevir) | Trials (telaprevir) | Recent Studies (post-2010) (telaprevir) |
|---|---|---|---|---|---|
| 1,102 | 246 | 590 | 985 | 136 | 835 |
| Protein | Taxonomy | atazanavir sulfate (IC50) | telaprevir (IC50) |
|---|---|---|---|
| NS3 protease | 0.9757 | ||
| Cathepsin L2 | Homo sapiens (human) | 1.35 | |
| Prothrombin | Homo sapiens (human) | 1 | |
| Plasminogen | Homo sapiens (human) | 8.7 | |
| Procathepsin L | Homo sapiens (human) | 3.5 | |
| Cathepsin B | Homo sapiens (human) | 2.3033 | |
| Neutrophil elastase | Homo sapiens (human) | 5.56 | |
| Chymase | Homo sapiens (human) | 0.026 | |
| Cathepsin S | Homo sapiens (human) | 0.3 | |
| Cathepsin K | Homo sapiens (human) | 0.63 | |
| Chymotrypsin-like elastase family member 1 | Homo sapiens (human) | 0.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castillo-Ferrando, JR; Espinosa, N; Gutierrez-Valencia, A; Lopez-Cortes, LF; Ruiz-Valderas, R; Torres-Cornejo, A; Viciana, P | 1 |
| Arends, JE; Burger, DM; de Kanter, CT; Hoepelman, AI; Jacobs, BS; van Elst-Laurijsen, DH; van Maarseveen, EM; Verwey-van Wissen, CP | 1 |
| Ferrer, E; Podzamczer, D; Van den Eynde, E | 1 |
| Cattaneo, D; Di Cristo, V; Gervasoni, C; Micheli, V; Milazzo, L | 1 |
| Barber, X; Gutiérrez, F; Lidón, F; Masiá, M; Padilla, S; Sanchis, M; Terol, G | 1 |
1 trial(s) available for atazanavir sulfate and telaprevir
| Article | Year |
|---|---|
Role of ritonavir in the drug interactions between telaprevir and ritonavir-boosted atazanavir.
Topics: Adult; Antiviral Agents; Atazanavir Sulfate; Chromatography, Liquid; Drug Interactions; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Mass Spectrometry; Middle Aged; Oligopeptides; Plasma; Pyridines; Ribavirin; Ritonavir | 2014 |
4 other study(ies) available for atazanavir sulfate and telaprevir
| Article | Year |
|---|---|
Managing drug-drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: a 'tour de force' for clinical pharmacologists.
Topics: Anticonvulsants; Antiviral Agents; Atazanavir Sulfate; Carbamazepine; Cytochrome P-450 CYP3A; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Enzyme Activation; Epilepsy; Hepatitis C; HIV Infections; Humans; Male; Middle Aged; Oligopeptides; Pyridines; Ritonavir; Treatment Outcome | 2014 |
Acute renal failure and liver toxicity in an HIV/hepatitis C coinfected patient receiving telaprevir and boosted atazanavir.
Topics: Acute Kidney Injury; Anti-HIV Agents; Atazanavir Sulfate; Hepatitis C, Chronic; HIV Infections; Humans; Middle Aged; Oligopeptides; Pyridines | 2014 |
Effect of hepatitis B and C clearance on atazanavir exposure.
Topics: Antiviral Agents; Atazanavir Sulfate; Hepatitis B; Hepatitis C; HIV Infections; Humans; Male; Oligopeptides | 2015 |
Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study.
Topics: Adult; Age Factors; Alkynes; Atazanavir Sulfate; Benzoxazines; CD4-CD8 Ratio; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Interferon Type I; Male; Middle Aged; Oligopeptides; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Ribavirin; Ritonavir | 2016 |